Letters in Drug Design and Discovery

Edit Your Profile

Letters in Drug Design and Discovery Journal

publication venue for

Oxime K033-reactivation Activity of Cholinesterases Inhibited by Various Nerve Agents and Organophosphorus Pesticides. 15:1124-1130. 2018
Alzheimer's Disease Drugs- In Vitro Comparison of Cholinesterase Inhibition and beta-amyloid Modulation. 14:743-750. 2017
TRISOXIME - a Bulky Trisquaternary Reactivator of Acetylcholinesterase. 13:372-375. 2016
SAR Study on Reactivators of Ethyl-Paraoxon Inhibited Acetylcholinesterase. 9:587-594. 2012
Ligand Based 3D-QSAR Study on a Series of Steroidal Human 5α-Reductase Inhibitors. 7:596-601. 2010
Potency of HI-6 to Reactivate Cyclosarin, Soman and Tabun Inhibited Acetylcholinesterase - In Vivo Study. 7:516-520. 2010
Self-Organizing Molecular Field Analysis on Pyridazine Analogues as Protein Tyrosine Phosphatase 1B (PTP 1B) Inhibitors. 7:395-401. 2010
Novel Nucleophilic Compounds with Oxime Group as Reactivators of Paraoxon-Inhibited Cholinesterases. 7:260-264. 2010
Synthesis and In Vitro Evaluation of Novel 1, 2, 4-Triazole Derivatives as Antifungal Agents. 7:46-49. 2010
Twelve different HI-6 salts and their potency to reactivate cyclosarin inhibited AChE in vitro. 4:510-512. 2007
Screening, Deconvolution and Parallel Synthesis of Trisubstituted Piperazine and Trisubstituted 2,3-diketopierazine Libraries for the Rapid Identification of Antagonists of the Nuclear Retinoic Acid Receptor-related Orphan Receptor Gamma (RORγ) 2024

International Standard Serial Number (ISSN)

1570-1808

Electronic International Standard Serial Number (EISSN)

1875-628X